Background and Objectives: G2019S) that increases risk of Parkinson disease (PD), assess participant satisfaction with a decentralized, remote research model, and evaluate interest in future clinical trials. Methods: G2019S carriers with PD, with prodromal PD, and without PD. Results: = 0.002). Two-thirds of participants enrolled were new to research, 97% were satisfied with the overall study, and 94% of those without PD would participate in future preventive clinical trials. Discussion: G2019S cohort, refine a new model of clinical research, and engage new research participants willing to participate in future therapeutic trials.
No takes yet. Share an insight, caveat, or question.
Jensen-Roberts et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: